IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
Kento Kawai(University of Oxford), Fadi Issa(Oxford Research Group)
Cited by 25
Related Papers
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
|Nature Immunology|2024|83
Systemic silencing of Phd2 causes reversible immune regulatory dysfunction
|Journal of Clinical Investigation|2019|35